FAAH inhibitor URB597 shows anti-hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF1 agonist mediated visceral hypersensitivity in male rats

By sjmartinez • October 1, 2024

Larauche M, Mulak A, Ha C, Million M, Arnett S, Germano P, Pearson JP, Currie MG, Taché Y. FAAH inhibitor URB597 shows anti-hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF₁ agonist mediated visceral hypersensitivity in male rats. Neurogastroenterol Motil. 2024 Sep 30:e14927. doi: 10.1111/nmo.14927. Epub ahead of print. PMID: 39344695.

Tags: anandamide, cortagine, defecation, Digestive Diseases, Irritable Bowel Syndrome, Publications, rat, URB597, Veterans Administration, Visceral pain

Annual cases of colon cancer by age group after Medicaid expansion in the USA in 2014: a difference-in-differences study

Asiimwe E, May F, Bendavid E. Annual cases of colon cancer by age group after Medicaid expansion in the USA in 2014: a difference-in-differences study.[...]

New Basic Science Editor and New Journal Management Committee Chair of Neurogastroenterology and Motility!

Corsetti M, Zerbib F, Black C, Shin A, Browning K, Keszthelyi D, Jones M. New Basic Science Editor and New Journal Management Committee Chair of[...]

Dietary Sugar and Sweetened Beverage Intake Increases Inflammatory Bowel Disease Risk: A Systematic Review and Meta-Analysis

Maniyar I, Jajoo A, Brewer GG, Iyengar P, Nguyen A, Fasulo C, White J, Parian A, Limketkai BN. Dietary Sugar and Sweetened Beverage Intake Increases[...]